Mark Sabag Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

TEVA Quotes by TradingView

Mark Sabag is EVP, International Markets of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 382,590 shares of TEVA, which is worth approximately $6.84 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 100,000 shares (Ordinary Shares) at a price of $13.52 per share, resulting in proceeds of $1,352,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 383K
0% 3M change
18.93% 12M change
Total Value Held $6.84 Million

Mark Sabag Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$1,352,000 $13.52 p/Share
100,000 Reduced 20.72%
382,590 Ordinary Shares
Mar 05 2024
BUY
Exercise of conversion of derivative security
-
81,897 Added 14.51%
482,590 Ordinary Shares
Mar 04 2024
BUY
Exercise of conversion of derivative security
-
33,512 Added 7.72%
400,693 Ordinary Shares
Mar 03 2024
BUY
Exercise of conversion of derivative security
-
24,900 Added 6.35%
367,181 Ordinary Shares
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
20,599 Added 5.68%
342,281 Ordinary Shares
Mar 05 2023
BUY
Exercise of conversion of derivative security
-
23,764 Added 6.88%
321,682 Ordinary Shares
Mar 04 2023
BUY
Exercise of conversion of derivative security
-
49,433 Added 14.23%
297,918 Ordinary Shares
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
70,840 Added 22.18%
248,485 Ordinary Shares
Mar 05 2022
BUY
Exercise of conversion of derivative security
-
23,764 Added 11.8%
177,645 Ordinary Shares
Mar 04 2022
BUY
Exercise of conversion of derivative security
-
59,278 Added 27.81%
153,881 Ordinary Shares
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
20,598 Added 17.88%
94,603 Ordinary Shares
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
15,523 Added 17.34%
74,005 Ordinary Shares
May 11 2021
BUY
Exercise of conversion of derivative security
-
37,884 Added 39.31%
58,482 Ordinary Shares
Mar 16 2021
SELL
Open market or private sale
$1,427,678 $11.22 p/Share
127,244 Reduced 86.07%
20,598 Ordinary Shares
Mar 04 2021
BUY
Exercise of conversion of derivative security
-
15,920 Added 9.72%
147,842 Ordinary Shares
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
20,598 Added 13.51%
131,922 Ordinary Shares
Feb 14 2021
BUY
Exercise of conversion of derivative security
-
5,712 Added 4.88%
111,324 Ordinary Shares
Feb 09 2021
BUY
Grant, award, or other acquisition
-
65,339 Added 38.22%
105,612 Ordinary Shares
Feb 09 2021
BUY
Exercise of conversion of derivative security
-
15,523 Added 27.82%
40,273 Ordinary Shares
MS

Mark Sabag

EVP, International Markets
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TEVA